WORLD J GASTROENTERO 润色咨询

WORLD JOURNAL OF GASTROENTEROLOGY

出版年份：1997 年文章数：12468 投稿命中率： 开通期刊会员，数据随心看

出版周期：Weekly 自引率：3.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2104612, encodeId=5f0f210461254, content=偏重的研究方向：消化病<br>经验分享：各位老师，Reviewing变成wait peer review是什么意思呀？我以前投WJCR，每次找到审稿人都会有邮件，这次一封都没有了，但是这周审稿人没有添加了，是不是意思是找到审稿人审稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Dec 06 19:12:32 CST 2022, time=2022-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2119820, encodeId=b72c21198209f, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec38179859, createdName=ms5000001365142656, createdTime=Wed Mar 15 23:13:36 CST 2023, time=2023-03-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=555493, encodeId=6c27555493d3, content=这个杂志不能添加共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e061708557, createdName=kingz1025, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069893, encodeId=576f10698932e, content=2021-10-13 投出，共四个审稿人，审稿意见回来分别是10月16.18.23.23，意见分别是大修，小修，拒，小修。截止2021-11-13号 状态还是reviewed。等的很焦急，明年就要毕业了、、、、, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48965428401, createdName=ms5000000383531396, createdTime=Sat Nov 13 14:51:14 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109788, encodeId=f7a62109e88ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：消化道肿瘤<br>经验分享：这个杂志是收到审稿人意见先不用回复吗，要等编辑部做出决定后再进行修改，或者直接拒绝吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4b41709924, createdName=1de9ea0cm23(暂无匿称), createdTime=Wed Jan 11 10:20:57 CST 2023, time=2023-01-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2109904, encodeId=07992109904a8, content=必须要所有参与患者签署的知情同意书嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a048504182, createdName=ms5000000342751166, createdTime=Wed Jan 11 23:46:04 CST 2023, time=2023-01-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108674, encodeId=3c3121086e4aa, content=审稿速度:2.0<br>偏重的研究方向：胃肠道;肿瘤<br>经验分享：投稿2个月，两个审稿人都给了accept，科学等级B和C，马连生给拒了，让转投到world journal of gastrointestinal surgery。白白浪费我时间和感情，这个期刊根本不算同行评审期刊，是CEO根据喜好来决定的，投稿过程也相当复杂，再也不会投这家期刊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6958339917, createdName=ms5000000560471001, createdTime=Tue Jan 03 20:20:00 CST 2023, time=2023-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574526, encodeId=f6bc5e45266c, content=我的说是不可以<span class="quote">毛哒熊 2019-08-07 00:00:00 发表:<br>这个杂志到底可不可以有共同一作啊？</span>, beContent=毛哒熊 2019-08-07 00:00:00 发表: 这个杂志到底可不可以有共同一作啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/4f2d7c3427b5c1d32ce5cb8375901961.jpg, createdBy=5b7d2103305, createdName=1831f6fd6em, createdTime=Wed Aug 07 00:00:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248513, encodeId=7dca124851312, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肝胆系统<br>经验分享：投稿后六个月见刊 编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Sep 12 16:37:47 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090382, encodeId=924c209038254, content=偏重的研究方向：胃肠道;胃肠道恶性肿瘤<br>经验分享：刚投了一篇，投稿系统设计的太复杂，伦理批件各种同意书上传了半天，居然还要了单位邮箱核实，结果完了邮箱也没有发现邮件核实，直接开拍审稿，速度好快，第一个审稿人意见很多，但给了大修，期待第二个审稿人意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Sep 26 00:47:41 CST 2022, time=2022-09-26, status=1, ipAttribution=)]
    2022-12-06 少年宁 来自浙江省

    偏重的研究方向：消化病
    经验分享：各位老师，Reviewing变成wait peer review是什么意思呀？我以前投WJCR，每次找到审稿人都会有邮件，这次一封都没有了，但是这周审稿人没有添加了，是不是意思是找到审稿人审稿了？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2104612, encodeId=5f0f210461254, content=偏重的研究方向：消化病<br>经验分享：各位老师，Reviewing变成wait peer review是什么意思呀？我以前投WJCR，每次找到审稿人都会有邮件，这次一封都没有了，但是这周审稿人没有添加了，是不是意思是找到审稿人审稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Dec 06 19:12:32 CST 2022, time=2022-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2119820, encodeId=b72c21198209f, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec38179859, createdName=ms5000001365142656, createdTime=Wed Mar 15 23:13:36 CST 2023, time=2023-03-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=555493, encodeId=6c27555493d3, content=这个杂志不能添加共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e061708557, createdName=kingz1025, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069893, encodeId=576f10698932e, content=2021-10-13 投出，共四个审稿人，审稿意见回来分别是10月16.18.23.23，意见分别是大修，小修，拒，小修。截止2021-11-13号 状态还是reviewed。等的很焦急，明年就要毕业了、、、、, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48965428401, createdName=ms5000000383531396, createdTime=Sat Nov 13 14:51:14 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109788, encodeId=f7a62109e88ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：消化道肿瘤<br>经验分享：这个杂志是收到审稿人意见先不用回复吗，要等编辑部做出决定后再进行修改，或者直接拒绝吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4b41709924, createdName=1de9ea0cm23(暂无匿称), createdTime=Wed Jan 11 10:20:57 CST 2023, time=2023-01-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2109904, encodeId=07992109904a8, content=必须要所有参与患者签署的知情同意书嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a048504182, createdName=ms5000000342751166, createdTime=Wed Jan 11 23:46:04 CST 2023, time=2023-01-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108674, encodeId=3c3121086e4aa, content=审稿速度:2.0<br>偏重的研究方向：胃肠道;肿瘤<br>经验分享：投稿2个月，两个审稿人都给了accept，科学等级B和C，马连生给拒了，让转投到world journal of gastrointestinal surgery。白白浪费我时间和感情，这个期刊根本不算同行评审期刊，是CEO根据喜好来决定的，投稿过程也相当复杂，再也不会投这家期刊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6958339917, createdName=ms5000000560471001, createdTime=Tue Jan 03 20:20:00 CST 2023, time=2023-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574526, encodeId=f6bc5e45266c, content=我的说是不可以<span class="quote">毛哒熊 2019-08-07 00:00:00 发表:<br>这个杂志到底可不可以有共同一作啊？</span>, beContent=毛哒熊 2019-08-07 00:00:00 发表: 这个杂志到底可不可以有共同一作啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/4f2d7c3427b5c1d32ce5cb8375901961.jpg, createdBy=5b7d2103305, createdName=1831f6fd6em, createdTime=Wed Aug 07 00:00:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248513, encodeId=7dca124851312, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肝胆系统<br>经验分享：投稿后六个月见刊 编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Sep 12 16:37:47 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090382, encodeId=924c209038254, content=偏重的研究方向：胃肠道;胃肠道恶性肿瘤<br>经验分享：刚投了一篇，投稿系统设计的太复杂，伦理批件各种同意书上传了半天，居然还要了单位邮箱核实，结果完了邮箱也没有发现邮件核实，直接开拍审稿，速度好快，第一个审稿人意见很多，但给了大修，期待第二个审稿人意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Sep 26 00:47:41 CST 2022, time=2022-09-26, status=1, ipAttribution=)]
    2023-03-15 ms5000001365142656 来自天津

    这个杂志收综述吗？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2104612, encodeId=5f0f210461254, content=偏重的研究方向：消化病<br>经验分享：各位老师，Reviewing变成wait peer review是什么意思呀？我以前投WJCR，每次找到审稿人都会有邮件，这次一封都没有了，但是这周审稿人没有添加了，是不是意思是找到审稿人审稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Dec 06 19:12:32 CST 2022, time=2022-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2119820, encodeId=b72c21198209f, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec38179859, createdName=ms5000001365142656, createdTime=Wed Mar 15 23:13:36 CST 2023, time=2023-03-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=555493, encodeId=6c27555493d3, content=这个杂志不能添加共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e061708557, createdName=kingz1025, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069893, encodeId=576f10698932e, content=2021-10-13 投出，共四个审稿人，审稿意见回来分别是10月16.18.23.23，意见分别是大修，小修，拒，小修。截止2021-11-13号 状态还是reviewed。等的很焦急，明年就要毕业了、、、、, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48965428401, createdName=ms5000000383531396, createdTime=Sat Nov 13 14:51:14 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109788, encodeId=f7a62109e88ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：消化道肿瘤<br>经验分享：这个杂志是收到审稿人意见先不用回复吗，要等编辑部做出决定后再进行修改，或者直接拒绝吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4b41709924, createdName=1de9ea0cm23(暂无匿称), createdTime=Wed Jan 11 10:20:57 CST 2023, time=2023-01-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2109904, encodeId=07992109904a8, content=必须要所有参与患者签署的知情同意书嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a048504182, createdName=ms5000000342751166, createdTime=Wed Jan 11 23:46:04 CST 2023, time=2023-01-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108674, encodeId=3c3121086e4aa, content=审稿速度:2.0<br>偏重的研究方向：胃肠道;肿瘤<br>经验分享：投稿2个月，两个审稿人都给了accept，科学等级B和C，马连生给拒了，让转投到world journal of gastrointestinal surgery。白白浪费我时间和感情，这个期刊根本不算同行评审期刊，是CEO根据喜好来决定的，投稿过程也相当复杂，再也不会投这家期刊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6958339917, createdName=ms5000000560471001, createdTime=Tue Jan 03 20:20:00 CST 2023, time=2023-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574526, encodeId=f6bc5e45266c, content=我的说是不可以<span class="quote">毛哒熊 2019-08-07 00:00:00 发表:<br>这个杂志到底可不可以有共同一作啊？</span>, beContent=毛哒熊 2019-08-07 00:00:00 发表: 这个杂志到底可不可以有共同一作啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/4f2d7c3427b5c1d32ce5cb8375901961.jpg, createdBy=5b7d2103305, createdName=1831f6fd6em, createdTime=Wed Aug 07 00:00:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248513, encodeId=7dca124851312, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肝胆系统<br>经验分享：投稿后六个月见刊 编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Sep 12 16:37:47 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090382, encodeId=924c209038254, content=偏重的研究方向：胃肠道;胃肠道恶性肿瘤<br>经验分享：刚投了一篇，投稿系统设计的太复杂，伦理批件各种同意书上传了半天，居然还要了单位邮箱核实，结果完了邮箱也没有发现邮件核实，直接开拍审稿，速度好快，第一个审稿人意见很多，但给了大修，期待第二个审稿人意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Sep 26 00:47:41 CST 2022, time=2022-09-26, status=1, ipAttribution=)]
    2018-04-27 kingz1025

    这个杂志不能添加共同第一作者吗

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2104612, encodeId=5f0f210461254, content=偏重的研究方向：消化病<br>经验分享：各位老师，Reviewing变成wait peer review是什么意思呀？我以前投WJCR，每次找到审稿人都会有邮件，这次一封都没有了，但是这周审稿人没有添加了，是不是意思是找到审稿人审稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Dec 06 19:12:32 CST 2022, time=2022-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2119820, encodeId=b72c21198209f, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec38179859, createdName=ms5000001365142656, createdTime=Wed Mar 15 23:13:36 CST 2023, time=2023-03-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=555493, encodeId=6c27555493d3, content=这个杂志不能添加共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e061708557, createdName=kingz1025, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069893, encodeId=576f10698932e, content=2021-10-13 投出，共四个审稿人，审稿意见回来分别是10月16.18.23.23，意见分别是大修，小修，拒，小修。截止2021-11-13号 状态还是reviewed。等的很焦急，明年就要毕业了、、、、, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48965428401, createdName=ms5000000383531396, createdTime=Sat Nov 13 14:51:14 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109788, encodeId=f7a62109e88ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：消化道肿瘤<br>经验分享：这个杂志是收到审稿人意见先不用回复吗，要等编辑部做出决定后再进行修改，或者直接拒绝吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4b41709924, createdName=1de9ea0cm23(暂无匿称), createdTime=Wed Jan 11 10:20:57 CST 2023, time=2023-01-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2109904, encodeId=07992109904a8, content=必须要所有参与患者签署的知情同意书嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a048504182, createdName=ms5000000342751166, createdTime=Wed Jan 11 23:46:04 CST 2023, time=2023-01-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108674, encodeId=3c3121086e4aa, content=审稿速度:2.0<br>偏重的研究方向：胃肠道;肿瘤<br>经验分享：投稿2个月，两个审稿人都给了accept，科学等级B和C，马连生给拒了，让转投到world journal of gastrointestinal surgery。白白浪费我时间和感情，这个期刊根本不算同行评审期刊，是CEO根据喜好来决定的，投稿过程也相当复杂，再也不会投这家期刊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6958339917, createdName=ms5000000560471001, createdTime=Tue Jan 03 20:20:00 CST 2023, time=2023-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574526, encodeId=f6bc5e45266c, content=我的说是不可以<span class="quote">毛哒熊 2019-08-07 00:00:00 发表:<br>这个杂志到底可不可以有共同一作啊？</span>, beContent=毛哒熊 2019-08-07 00:00:00 发表: 这个杂志到底可不可以有共同一作啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/4f2d7c3427b5c1d32ce5cb8375901961.jpg, createdBy=5b7d2103305, createdName=1831f6fd6em, createdTime=Wed Aug 07 00:00:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248513, encodeId=7dca124851312, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肝胆系统<br>经验分享：投稿后六个月见刊 编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Sep 12 16:37:47 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090382, encodeId=924c209038254, content=偏重的研究方向：胃肠道;胃肠道恶性肿瘤<br>经验分享：刚投了一篇，投稿系统设计的太复杂，伦理批件各种同意书上传了半天，居然还要了单位邮箱核实，结果完了邮箱也没有发现邮件核实，直接开拍审稿，速度好快，第一个审稿人意见很多，但给了大修，期待第二个审稿人意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Sep 26 00:47:41 CST 2022, time=2022-09-26, status=1, ipAttribution=)]
    2021-11-13 ms5000000383531396

    2021-10-13 投出，共四个审稿人，审稿意见回来分别是10月16.18.23.23，意见分别是大修，小修，拒，小修。截止2021-11-13号 状态还是reviewed。等的很焦急，明年就要毕业了、、、、

    12

    展开12条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2104612, encodeId=5f0f210461254, content=偏重的研究方向：消化病<br>经验分享：各位老师，Reviewing变成wait peer review是什么意思呀？我以前投WJCR，每次找到审稿人都会有邮件，这次一封都没有了，但是这周审稿人没有添加了，是不是意思是找到审稿人审稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Dec 06 19:12:32 CST 2022, time=2022-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2119820, encodeId=b72c21198209f, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec38179859, createdName=ms5000001365142656, createdTime=Wed Mar 15 23:13:36 CST 2023, time=2023-03-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=555493, encodeId=6c27555493d3, content=这个杂志不能添加共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e061708557, createdName=kingz1025, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069893, encodeId=576f10698932e, content=2021-10-13 投出，共四个审稿人，审稿意见回来分别是10月16.18.23.23，意见分别是大修，小修，拒，小修。截止2021-11-13号 状态还是reviewed。等的很焦急，明年就要毕业了、、、、, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48965428401, createdName=ms5000000383531396, createdTime=Sat Nov 13 14:51:14 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109788, encodeId=f7a62109e88ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：消化道肿瘤<br>经验分享：这个杂志是收到审稿人意见先不用回复吗，要等编辑部做出决定后再进行修改，或者直接拒绝吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4b41709924, createdName=1de9ea0cm23(暂无匿称), createdTime=Wed Jan 11 10:20:57 CST 2023, time=2023-01-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2109904, encodeId=07992109904a8, content=必须要所有参与患者签署的知情同意书嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a048504182, createdName=ms5000000342751166, createdTime=Wed Jan 11 23:46:04 CST 2023, time=2023-01-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108674, encodeId=3c3121086e4aa, content=审稿速度:2.0<br>偏重的研究方向：胃肠道;肿瘤<br>经验分享：投稿2个月，两个审稿人都给了accept，科学等级B和C，马连生给拒了，让转投到world journal of gastrointestinal surgery。白白浪费我时间和感情，这个期刊根本不算同行评审期刊，是CEO根据喜好来决定的，投稿过程也相当复杂，再也不会投这家期刊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6958339917, createdName=ms5000000560471001, createdTime=Tue Jan 03 20:20:00 CST 2023, time=2023-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574526, encodeId=f6bc5e45266c, content=我的说是不可以<span class="quote">毛哒熊 2019-08-07 00:00:00 发表:<br>这个杂志到底可不可以有共同一作啊？</span>, beContent=毛哒熊 2019-08-07 00:00:00 发表: 这个杂志到底可不可以有共同一作啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/4f2d7c3427b5c1d32ce5cb8375901961.jpg, createdBy=5b7d2103305, createdName=1831f6fd6em, createdTime=Wed Aug 07 00:00:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248513, encodeId=7dca124851312, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肝胆系统<br>经验分享：投稿后六个月见刊 编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Sep 12 16:37:47 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090382, encodeId=924c209038254, content=偏重的研究方向：胃肠道;胃肠道恶性肿瘤<br>经验分享：刚投了一篇，投稿系统设计的太复杂，伦理批件各种同意书上传了半天，居然还要了单位邮箱核实，结果完了邮箱也没有发现邮件核实，直接开拍审稿，速度好快，第一个审稿人意见很多，但给了大修，期待第二个审稿人意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Sep 26 00:47:41 CST 2022, time=2022-09-26, status=1, ipAttribution=)]
    2023-01-11 1de9ea0cm23(暂无匿称) 来自辽宁省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：消化道肿瘤
    经验分享：这个杂志是收到审稿人意见先不用回复吗，要等编辑部做出决定后再进行修改，或者直接拒绝吗？

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2104612, encodeId=5f0f210461254, content=偏重的研究方向：消化病<br>经验分享：各位老师，Reviewing变成wait peer review是什么意思呀？我以前投WJCR，每次找到审稿人都会有邮件，这次一封都没有了，但是这周审稿人没有添加了，是不是意思是找到审稿人审稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Dec 06 19:12:32 CST 2022, time=2022-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2119820, encodeId=b72c21198209f, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec38179859, createdName=ms5000001365142656, createdTime=Wed Mar 15 23:13:36 CST 2023, time=2023-03-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=555493, encodeId=6c27555493d3, content=这个杂志不能添加共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e061708557, createdName=kingz1025, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069893, encodeId=576f10698932e, content=2021-10-13 投出，共四个审稿人，审稿意见回来分别是10月16.18.23.23，意见分别是大修，小修，拒，小修。截止2021-11-13号 状态还是reviewed。等的很焦急，明年就要毕业了、、、、, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48965428401, createdName=ms5000000383531396, createdTime=Sat Nov 13 14:51:14 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109788, encodeId=f7a62109e88ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：消化道肿瘤<br>经验分享：这个杂志是收到审稿人意见先不用回复吗，要等编辑部做出决定后再进行修改，或者直接拒绝吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4b41709924, createdName=1de9ea0cm23(暂无匿称), createdTime=Wed Jan 11 10:20:57 CST 2023, time=2023-01-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2109904, encodeId=07992109904a8, content=必须要所有参与患者签署的知情同意书嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a048504182, createdName=ms5000000342751166, createdTime=Wed Jan 11 23:46:04 CST 2023, time=2023-01-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108674, encodeId=3c3121086e4aa, content=审稿速度:2.0<br>偏重的研究方向：胃肠道;肿瘤<br>经验分享：投稿2个月，两个审稿人都给了accept，科学等级B和C，马连生给拒了，让转投到world journal of gastrointestinal surgery。白白浪费我时间和感情，这个期刊根本不算同行评审期刊，是CEO根据喜好来决定的，投稿过程也相当复杂，再也不会投这家期刊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6958339917, createdName=ms5000000560471001, createdTime=Tue Jan 03 20:20:00 CST 2023, time=2023-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574526, encodeId=f6bc5e45266c, content=我的说是不可以<span class="quote">毛哒熊 2019-08-07 00:00:00 发表:<br>这个杂志到底可不可以有共同一作啊？</span>, beContent=毛哒熊 2019-08-07 00:00:00 发表: 这个杂志到底可不可以有共同一作啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/4f2d7c3427b5c1d32ce5cb8375901961.jpg, createdBy=5b7d2103305, createdName=1831f6fd6em, createdTime=Wed Aug 07 00:00:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248513, encodeId=7dca124851312, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肝胆系统<br>经验分享：投稿后六个月见刊 编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Sep 12 16:37:47 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090382, encodeId=924c209038254, content=偏重的研究方向：胃肠道;胃肠道恶性肿瘤<br>经验分享：刚投了一篇，投稿系统设计的太复杂，伦理批件各种同意书上传了半天，居然还要了单位邮箱核实，结果完了邮箱也没有发现邮件核实，直接开拍审稿，速度好快，第一个审稿人意见很多，但给了大修，期待第二个审稿人意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Sep 26 00:47:41 CST 2022, time=2022-09-26, status=1, ipAttribution=)]
    2023-01-11 ms5000000342751166 来自江苏省

    必须要所有参与患者签署的知情同意书嘛？

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2104612, encodeId=5f0f210461254, content=偏重的研究方向：消化病<br>经验分享：各位老师，Reviewing变成wait peer review是什么意思呀？我以前投WJCR，每次找到审稿人都会有邮件，这次一封都没有了，但是这周审稿人没有添加了，是不是意思是找到审稿人审稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Dec 06 19:12:32 CST 2022, time=2022-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2119820, encodeId=b72c21198209f, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec38179859, createdName=ms5000001365142656, createdTime=Wed Mar 15 23:13:36 CST 2023, time=2023-03-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=555493, encodeId=6c27555493d3, content=这个杂志不能添加共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e061708557, createdName=kingz1025, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069893, encodeId=576f10698932e, content=2021-10-13 投出，共四个审稿人，审稿意见回来分别是10月16.18.23.23，意见分别是大修，小修，拒，小修。截止2021-11-13号 状态还是reviewed。等的很焦急，明年就要毕业了、、、、, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48965428401, createdName=ms5000000383531396, createdTime=Sat Nov 13 14:51:14 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109788, encodeId=f7a62109e88ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：消化道肿瘤<br>经验分享：这个杂志是收到审稿人意见先不用回复吗，要等编辑部做出决定后再进行修改，或者直接拒绝吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4b41709924, createdName=1de9ea0cm23(暂无匿称), createdTime=Wed Jan 11 10:20:57 CST 2023, time=2023-01-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2109904, encodeId=07992109904a8, content=必须要所有参与患者签署的知情同意书嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a048504182, createdName=ms5000000342751166, createdTime=Wed Jan 11 23:46:04 CST 2023, time=2023-01-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108674, encodeId=3c3121086e4aa, content=审稿速度:2.0<br>偏重的研究方向：胃肠道;肿瘤<br>经验分享：投稿2个月，两个审稿人都给了accept，科学等级B和C，马连生给拒了，让转投到world journal of gastrointestinal surgery。白白浪费我时间和感情，这个期刊根本不算同行评审期刊，是CEO根据喜好来决定的，投稿过程也相当复杂，再也不会投这家期刊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6958339917, createdName=ms5000000560471001, createdTime=Tue Jan 03 20:20:00 CST 2023, time=2023-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574526, encodeId=f6bc5e45266c, content=我的说是不可以<span class="quote">毛哒熊 2019-08-07 00:00:00 发表:<br>这个杂志到底可不可以有共同一作啊？</span>, beContent=毛哒熊 2019-08-07 00:00:00 发表: 这个杂志到底可不可以有共同一作啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/4f2d7c3427b5c1d32ce5cb8375901961.jpg, createdBy=5b7d2103305, createdName=1831f6fd6em, createdTime=Wed Aug 07 00:00:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248513, encodeId=7dca124851312, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肝胆系统<br>经验分享：投稿后六个月见刊 编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Sep 12 16:37:47 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090382, encodeId=924c209038254, content=偏重的研究方向：胃肠道;胃肠道恶性肿瘤<br>经验分享：刚投了一篇，投稿系统设计的太复杂，伦理批件各种同意书上传了半天，居然还要了单位邮箱核实，结果完了邮箱也没有发现邮件核实，直接开拍审稿，速度好快，第一个审稿人意见很多，但给了大修，期待第二个审稿人意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Sep 26 00:47:41 CST 2022, time=2022-09-26, status=1, ipAttribution=)]
    2023-01-03 ms5000000560471001 来自北京

    审稿速度:2.0
    偏重的研究方向：胃肠道;肿瘤
    经验分享：投稿2个月，两个审稿人都给了accept，科学等级B和C，马连生给拒了，让转投到world journal of gastrointestinal surgery。白白浪费我时间和感情，这个期刊根本不算同行评审期刊，是CEO根据喜好来决定的，投稿过程也相当复杂，再也不会投这家期刊了。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2104612, encodeId=5f0f210461254, content=偏重的研究方向：消化病<br>经验分享：各位老师，Reviewing变成wait peer review是什么意思呀？我以前投WJCR，每次找到审稿人都会有邮件，这次一封都没有了，但是这周审稿人没有添加了，是不是意思是找到审稿人审稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Dec 06 19:12:32 CST 2022, time=2022-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2119820, encodeId=b72c21198209f, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec38179859, createdName=ms5000001365142656, createdTime=Wed Mar 15 23:13:36 CST 2023, time=2023-03-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=555493, encodeId=6c27555493d3, content=这个杂志不能添加共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e061708557, createdName=kingz1025, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069893, encodeId=576f10698932e, content=2021-10-13 投出，共四个审稿人，审稿意见回来分别是10月16.18.23.23，意见分别是大修，小修，拒，小修。截止2021-11-13号 状态还是reviewed。等的很焦急，明年就要毕业了、、、、, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48965428401, createdName=ms5000000383531396, createdTime=Sat Nov 13 14:51:14 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109788, encodeId=f7a62109e88ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：消化道肿瘤<br>经验分享：这个杂志是收到审稿人意见先不用回复吗，要等编辑部做出决定后再进行修改，或者直接拒绝吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4b41709924, createdName=1de9ea0cm23(暂无匿称), createdTime=Wed Jan 11 10:20:57 CST 2023, time=2023-01-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2109904, encodeId=07992109904a8, content=必须要所有参与患者签署的知情同意书嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a048504182, createdName=ms5000000342751166, createdTime=Wed Jan 11 23:46:04 CST 2023, time=2023-01-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108674, encodeId=3c3121086e4aa, content=审稿速度:2.0<br>偏重的研究方向：胃肠道;肿瘤<br>经验分享：投稿2个月，两个审稿人都给了accept，科学等级B和C，马连生给拒了，让转投到world journal of gastrointestinal surgery。白白浪费我时间和感情，这个期刊根本不算同行评审期刊，是CEO根据喜好来决定的，投稿过程也相当复杂，再也不会投这家期刊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6958339917, createdName=ms5000000560471001, createdTime=Tue Jan 03 20:20:00 CST 2023, time=2023-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574526, encodeId=f6bc5e45266c, content=我的说是不可以<span class="quote">毛哒熊 2019-08-07 00:00:00 发表:<br>这个杂志到底可不可以有共同一作啊？</span>, beContent=毛哒熊 2019-08-07 00:00:00 发表: 这个杂志到底可不可以有共同一作啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/4f2d7c3427b5c1d32ce5cb8375901961.jpg, createdBy=5b7d2103305, createdName=1831f6fd6em, createdTime=Wed Aug 07 00:00:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248513, encodeId=7dca124851312, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肝胆系统<br>经验分享：投稿后六个月见刊 编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Sep 12 16:37:47 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090382, encodeId=924c209038254, content=偏重的研究方向：胃肠道;胃肠道恶性肿瘤<br>经验分享：刚投了一篇，投稿系统设计的太复杂，伦理批件各种同意书上传了半天，居然还要了单位邮箱核实，结果完了邮箱也没有发现邮件核实，直接开拍审稿，速度好快，第一个审稿人意见很多，但给了大修，期待第二个审稿人意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Sep 26 00:47:41 CST 2022, time=2022-09-26, status=1, ipAttribution=)]
    2019-08-07 1831f6fd6em

    我的说是不可以毛哒熊 2019-08-07 00:00:00 发表:
    这个杂志到底可不可以有共同一作啊？

    毛哒熊 2019-08-07 00:00:00 发表: 这个杂志到底可不可以有共同一作啊？

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2104612, encodeId=5f0f210461254, content=偏重的研究方向：消化病<br>经验分享：各位老师，Reviewing变成wait peer review是什么意思呀？我以前投WJCR，每次找到审稿人都会有邮件，这次一封都没有了，但是这周审稿人没有添加了，是不是意思是找到审稿人审稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Dec 06 19:12:32 CST 2022, time=2022-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2119820, encodeId=b72c21198209f, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec38179859, createdName=ms5000001365142656, createdTime=Wed Mar 15 23:13:36 CST 2023, time=2023-03-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=555493, encodeId=6c27555493d3, content=这个杂志不能添加共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e061708557, createdName=kingz1025, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069893, encodeId=576f10698932e, content=2021-10-13 投出，共四个审稿人，审稿意见回来分别是10月16.18.23.23，意见分别是大修，小修，拒，小修。截止2021-11-13号 状态还是reviewed。等的很焦急，明年就要毕业了、、、、, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48965428401, createdName=ms5000000383531396, createdTime=Sat Nov 13 14:51:14 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109788, encodeId=f7a62109e88ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：消化道肿瘤<br>经验分享：这个杂志是收到审稿人意见先不用回复吗，要等编辑部做出决定后再进行修改，或者直接拒绝吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4b41709924, createdName=1de9ea0cm23(暂无匿称), createdTime=Wed Jan 11 10:20:57 CST 2023, time=2023-01-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2109904, encodeId=07992109904a8, content=必须要所有参与患者签署的知情同意书嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a048504182, createdName=ms5000000342751166, createdTime=Wed Jan 11 23:46:04 CST 2023, time=2023-01-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108674, encodeId=3c3121086e4aa, content=审稿速度:2.0<br>偏重的研究方向：胃肠道;肿瘤<br>经验分享：投稿2个月，两个审稿人都给了accept，科学等级B和C，马连生给拒了，让转投到world journal of gastrointestinal surgery。白白浪费我时间和感情，这个期刊根本不算同行评审期刊，是CEO根据喜好来决定的，投稿过程也相当复杂，再也不会投这家期刊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6958339917, createdName=ms5000000560471001, createdTime=Tue Jan 03 20:20:00 CST 2023, time=2023-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574526, encodeId=f6bc5e45266c, content=我的说是不可以<span class="quote">毛哒熊 2019-08-07 00:00:00 发表:<br>这个杂志到底可不可以有共同一作啊？</span>, beContent=毛哒熊 2019-08-07 00:00:00 发表: 这个杂志到底可不可以有共同一作啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/4f2d7c3427b5c1d32ce5cb8375901961.jpg, createdBy=5b7d2103305, createdName=1831f6fd6em, createdTime=Wed Aug 07 00:00:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248513, encodeId=7dca124851312, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肝胆系统<br>经验分享：投稿后六个月见刊 编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Sep 12 16:37:47 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090382, encodeId=924c209038254, content=偏重的研究方向：胃肠道;胃肠道恶性肿瘤<br>经验分享：刚投了一篇，投稿系统设计的太复杂，伦理批件各种同意书上传了半天，居然还要了单位邮箱核实，结果完了邮箱也没有发现邮件核实，直接开拍审稿，速度好快，第一个审稿人意见很多，但给了大修，期待第二个审稿人意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Sep 26 00:47:41 CST 2022, time=2022-09-26, status=1, ipAttribution=)]
    2022-09-12 ms6000000536352595

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：肝胆系统
    经验分享：投稿后六个月见刊 编辑友好

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2104612, encodeId=5f0f210461254, content=偏重的研究方向：消化病<br>经验分享：各位老师，Reviewing变成wait peer review是什么意思呀？我以前投WJCR，每次找到审稿人都会有邮件，这次一封都没有了，但是这周审稿人没有添加了，是不是意思是找到审稿人审稿了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Tue Dec 06 19:12:32 CST 2022, time=2022-12-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2119820, encodeId=b72c21198209f, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ec38179859, createdName=ms5000001365142656, createdTime=Wed Mar 15 23:13:36 CST 2023, time=2023-03-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=555493, encodeId=6c27555493d3, content=这个杂志不能添加共同第一作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e061708557, createdName=kingz1025, createdTime=Fri Apr 27 00:00:00 CST 2018, time=2018-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069893, encodeId=576f10698932e, content=2021-10-13 投出，共四个审稿人，审稿意见回来分别是10月16.18.23.23，意见分别是大修，小修，拒，小修。截止2021-11-13号 状态还是reviewed。等的很焦急，明年就要毕业了、、、、, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48965428401, createdName=ms5000000383531396, createdTime=Sat Nov 13 14:51:14 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109788, encodeId=f7a62109e88ca, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：消化道肿瘤<br>经验分享：这个杂志是收到审稿人意见先不用回复吗，要等编辑部做出决定后再进行修改，或者直接拒绝吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4b41709924, createdName=1de9ea0cm23(暂无匿称), createdTime=Wed Jan 11 10:20:57 CST 2023, time=2023-01-11, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2109904, encodeId=07992109904a8, content=必须要所有参与患者签署的知情同意书嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a048504182, createdName=ms5000000342751166, createdTime=Wed Jan 11 23:46:04 CST 2023, time=2023-01-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108674, encodeId=3c3121086e4aa, content=审稿速度:2.0<br>偏重的研究方向：胃肠道;肿瘤<br>经验分享：投稿2个月，两个审稿人都给了accept，科学等级B和C，马连生给拒了，让转投到world journal of gastrointestinal surgery。白白浪费我时间和感情，这个期刊根本不算同行评审期刊，是CEO根据喜好来决定的，投稿过程也相当复杂，再也不会投这家期刊了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6958339917, createdName=ms5000000560471001, createdTime=Tue Jan 03 20:20:00 CST 2023, time=2023-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=574526, encodeId=f6bc5e45266c, content=我的说是不可以<span class="quote">毛哒熊 2019-08-07 00:00:00 发表:<br>这个杂志到底可不可以有共同一作啊？</span>, beContent=毛哒熊 2019-08-07 00:00:00 发表: 这个杂志到底可不可以有共同一作啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/25/4f2d7c3427b5c1d32ce5cb8375901961.jpg, createdBy=5b7d2103305, createdName=1831f6fd6em, createdTime=Wed Aug 07 00:00:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248513, encodeId=7dca124851312, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肝胆系统<br>经验分享：投稿后六个月见刊 编辑友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Sep 12 16:37:47 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090382, encodeId=924c209038254, content=偏重的研究方向：胃肠道;胃肠道恶性肿瘤<br>经验分享：刚投了一篇，投稿系统设计的太复杂，伦理批件各种同意书上传了半天，居然还要了单位邮箱核实，结果完了邮箱也没有发现邮件核实，直接开拍审稿，速度好快，第一个审稿人意见很多，但给了大修，期待第二个审稿人意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Sep 26 00:47:41 CST 2022, time=2022-09-26, status=1, ipAttribution=)]
    2022-09-26 shademei

    偏重的研究方向：胃肠道;胃肠道恶性肿瘤
    经验分享：刚投了一篇，投稿系统设计的太复杂，伦理批件各种同意书上传了半天，居然还要了单位邮箱核实，结果完了邮箱也没有发现邮件核实，直接开拍审稿，速度好快，第一个审稿人意见很多，但给了大修，期待第二个审稿人意见

    1

    展开1条回复
共500条页码: 3/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分